GlassScriptPhysician profile
Kevin C Mcdonald
NPI 1992810717
$7,721.19
in general payments reported to CMS, 2019-2025
34 companies · $581 in 2025
The $581 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,941 · 2020: $593 · 2021: $256 · 2022: $596 · 2023: $316 · 2024: $438 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,334.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modulated Imaging, INC. | $4,021.32 | 2019-2020 | |
| Smith+Nephew, INC. | $718.02 | 2019-2024 | Pico 7, Renasys Go V2 Home, Renasys Touch |
| Medline Industries LP | $600.00 | 2019 | |
| Horizon Therapeutics Plc | $289.66 | 2019-2023 | Krystexxa |
| Stryker Corporation | $246.53 | 2022-2025 | Prostep, Ortholoc 2 Lapifuse, Easyfuse |
| Convatec INC. | $212.91 | 2024 | |
| Kerecis Limited | $181.39 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $144.50 | 2022-2025 | |
| Depuy Synthes Sales INC. | $144.14 | 2025 | Motoband |
| Bioventus LLC | $121.51 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Triad Life Sciences INC. | $106.53 | 2022 | |
| Amniox Medical, INC. | $93.75 | 2019 | |
| Medtronic, INC. | $84.56 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Grt US Holding, INC. | $80.25 | 2022 | |
| Paratek Pharmaceuticals, INC. | $80.21 | 2022-2023 | Nuzyra |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $64.62 | 2020 | |
| Globus Medical, INC. | $60.86 | 2025 | Senza, Omnia |
| Progenacare Global, LLC | $52.30 | 2023 | |
| Next Science LLC | $51.40 | 2023 | Xperience, Blastx, Surgx |
| Integra Lifesciences Corporation | $46.04 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Peerless Surgical INC. | $37.45 | 2025 | |
| Tactile Systems Technology INC | $34.47 | 2019-2025 | Nimbl, Flexitouch Plus |
| Abbott Laboratories | $27.68 | 2025 | Eterna |
| Zimmer Biomet Holdings, INC. | $27.33 | 2019 | |
| Boston Scientific Corporation | $24.79 | 2024 | |
| Mimedx Group, INC. | $24.10 | 2024 | |
| Amgen INC. | $23.20 | 2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $22.76 | 2025 | |
| Osiris Therapeutics INC. | $19.68 | 2019 | |
| Organogenesis INC. | $18.51 | 2024 | |
| Nevro Corp. | $17.03 | 2024 | Senza |
| Polymedics Innovations INC. | $16.26 | 2024 | |
| Heron Therapeutics, INC. | $15.50 | 2021 | |
| Merck Sharp & Dohme LLC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.